Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.

Shanghai Mental Health Center200 enrolled

Overview

The purpose of this research is to evaluate the efficacy and safety of Robot-assisted rehabilitation intelligent system as a virtual stand-alone treatment, delivered with minimal clinical monitoring compared with treatment as usual in methamphetamine (MA) use disorders.

Based on artificial intelligence technology, face recognition technology, virtual reality technology to develop an available Robot-assisted rehabilitation intelligent system. Then, using this intelligent system as a new way of Psychotherapy to provide treatment for methamphetamine patients, and compare it with traditional treatment to verify the efficacy and safety of Robot-assisted rehabilitation intelligent system in Chinese methamphetamine patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

200

Conditions

Amphetamine Addiction

Interventions

robot-assisted rehabilitation intelligent treatmentDEVICE

robot-assisted rehabilitation psychotherapy

standard psychotherapy treatmentOTHER

standard treatment at the compulsory isolated detoxification centers and non-compulsory isolated detoxification institutions

Eligibility

Sex: ALLMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders; * Education level equal or more than 9 years; * Have normal or corrected-to-normal vision; * Have normal or corrected-to-normal hearing; * Less than 3 months before last drug use; Exclusion Criteria: * Current substance use (except nicotine or caffeine); * History of disease which influence cognition，such as seizure disorder、cerebrovascular disease、head injury or other severe medication conditions; * Intelligence quotient less than 70.

Locations (1)

Shanghai Gaojing Rehabilitation Center

Shanghai, China

RECRUITING

Outcomes

Primary Outcomes

Changes of galvanic skin response during the virtual reality based addiction assessment system

The galvanic skin response is an emotional physiological indicator, and its unit is ohm.

Time frame: in 1 year

Secondary Outcomes

Treatment motivation

Using the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) to measure the treatment motivation of the participants. The score of the scale is between 19 and 95. The higher the score, the higher the treatment motivation.

Time frame: in 1 year

Anxiety

Anxiety is assessed by the State-Trait Anxiety Scale (SAS). The score of the SAS scale is between 0 and 80. The higher the score, the more severe the anxiety symptoms.

Time frame: in 1 year

Depression

Depression is assessed by the the Beck Depression Scale (SDS). The score of the SDS scale is between 0 and 80. The higher the score, the more severe the depression symptoms.

Time frame: in 1 year

Attentional bias related to drugs and emotional stimulation

The emotional Stroop tests is used for assessed attentional bias. The indicator is the accuracy rate of the key presses, from 0 to 100%.

Time frame: in 1 year

Risky decision-making

Balloon Analogue Risk Task is used for assess the risky decision-making ability. The indicator is the average number of balloon blows, and its unit is times.

Time frame: in 1 year

Reaction inhibition ability

Stop signal task is used for assess the reaction inhibition ability. The indicator is the reaction time when the participant completes the task, and its unit is milliseconds.

Central Contacts

Min Zhao

CONTACT

64387250 drminzhao@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.